C000265138 Holdings — Portfolio Building Block World Pharma and Biotech Index ETF
All 52 reported holdings of Portfolio Building Block World Pharma and Biotech Index ETF (C000265138) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly & Co. | 0.15% | $5.28M |
| Johnson & Johnson | 0.09% | $3.26M |
| Abbvie, Inc. | 0.07% | $2.34M |
| Roche Holding AG-Genusschein | 0.05% | $1.89M |
| Novartis AG-Reg | 0.05% | $1.79M |
| Merck & Co. Inc. | 0.05% | $1.69M |
| Astrazeneca PLC | 0.05% | $1.65M |
| Novo Nordisk A/s-B | 0.04% | $1.57M |
| Amgen, Inc. | 0.04% | $1.55M |
| Gilead Sciences, Inc. | 0.04% | $1.47M |
| Pfizer, Inc. | 0.03% | $1.25M |
| Vertex Pharmaceuticals | 0.03% | $978.33K |
| Bristol-Myers Squibb Co. | 0.03% | $934.53K |
| Sanofi | 0.02% | $897.17K |
| Gsk PLC | 0.02% | $849.30K |
| Regeneron Pharmaceuticals | 0.02% | $617.63K |
| Csl Ltd. | 0.01% | $508.88K |
| Zoetis, Inc. | 0.01% | $465.08K |
| Takeda Pharmaceutical Co. Ltd. | 0.01% | $461.47K |
| Argenx SE | 0.01% | $452.97K |
| Bayer AG-Reg | 0.01% | $431.62K |
| Haleon PLC | 0.01% | $378.85K |
| Alnylam Pharmacy | 0.01% | $368.82K |
| Teva Pharmaceutical Ind Ltd. | 0.01% | $306.92K |
| Ucb SA | 0.01% | $296.24K |
| Insmed, Inc. | 0.01% | $281.42K |
| Sandoz Group AG | 0.01% | $274.10K |
| Natera, Inc. | 0.01% | $255.18K |
| Daiichi Sankyo Co. Ltd. | 0.01% | $253.71K |
| Chugai Pharmaceutical Co. Ltd. | 0.01% | $244.02K |
| Biogen, Inc. | 0.01% | $223.24K |
| Dreyfus Trsry Securities | 0.01% | $203.75K |
| Galderma Group AG | 0.01% | $206.31K |
| Astellas Pharma, Inc. | 0.01% | $192.25K |
| United Therapeutics Corp. | 0.01% | $185.45K |
| Otsuka Holdings Co. Ltd. | 0.00% | $172.95K |
| Genmab A/s | 0.00% | $172.33K |
| Incyte Corp. | 0.00% | $165.72K |
| Merck Kgaa | 0.00% | $164.75K |
| Exact Sciences Corp. | 0.00% | $155.35K |
| Revolution Medicines, Inc. | 0.00% | $133.79K |
| Viatris, Inc. | 0.00% | $124.64K |
| Royalty Pharma PLC- Cl A | 0.00% | $120.79K |
| Ionis Pharmaceuticals, Inc. | 0.00% | $114.00K |
| Neurocine Biosciences | 0.00% | $112.52K |
| Bridgebio Pharma, Inc. | 0.00% | $106.56K |
| Elanco Animal Health, Inc. | 0.00% | $99.67K |
| Shionogi & Co. Ltd. | 0.00% | $90.99K |
| Biomarin Pharmaceutical, Inc. | 0.00% | $85.83K |
| Exelixis, Inc. | 0.00% | $85.70K |
| Madrigal Pharmaceuticals | 0.00% | $72.42K |
| Roche Holding AG-Br | 0.00% | $68.42K |
C000265138 overview: performance, fees, allocation and SEC filings